Cargando…

Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma

OBJECTIVE: Hypercalcemia is a common finding in patients who have an underlying malignancy. Only a few cases of hypercalcemia of malignancy have been linked to more than one mechanism of hypercalcemia. Here, we present a patient with liposarcoma and hypercalcemia of malignancy in the setting of simu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Won, Miller, Ann, Li, Andrew, Hardy, Naomi, Silver, Kristi D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association of Clinical Endocrinology 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165116/ https://www.ncbi.nlm.nih.gov/pubmed/34095480 http://dx.doi.org/10.1016/j.aace.2020.11.037

Ejemplares similares

1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2014)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

Severe Hypercalcemia From Inhalation Pneumonitis via Activation of 1,25 Dihydroxyvitamin D
por: Rosenstein, Kyle, et al.
Publicado: (2022)

Hypercalcemia Due to Paraneoplastic Production of 1,25- Dihydroxyvitamin D in a Young Female with Dysgerminoma
por: Iqbal, Iqra, et al.
Publicado: (2019)

SAT257 Efficacy Of Oral Cinacalcet In Non-PTH Non-Malignant Hypercalcemia From Excess 1,25 Dihydroxyvitamin D
por: Mohan, Sneha, et al.
Publicado: (2023)

Vitamin D Status among Thai School Children and the Association with 1,25-Dihydroxyvitamin D and Parathyroid Hormone Levels
por: Houghton, Lisa A., et al.
Publicado: (2014)

Textiloma-Induced 1,25-Dihydroxyvitamin D–Mediated Hypercalcemia: A Case Report and Literature Study
por: de Bellefroid, Julie, et al.
Publicado: (2019)

Hypercalcemia Owing to Overproduction of 1,25-Dihydroxyvitamin D(3) in Fetal Lung Adenocarcinoma: Case Report
por: Saito, Tomohito, et al.
Publicado: (2021)

Successful Treatment for Hypercalcemia due to Cosecretion of Parathyroid Hormone-Related Protein and 1,25-Dihydroxyvitamin D(3) in Non-Small-Cell Lung Cancer: A Case Report and Literature Review
por: Ogawa, Takunori, et al.
Publicado: (2020)

Malignant Hypercalcemia Induced by the Ectopic Production of Intact Parathyroid Hormone (PTH)
por: Neves, Ana, et al.
Publicado: (2023)

THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
por: Brown, Jeremy, et al.
Publicado: (2023)

Hypercalcemia in Small Lymphocytic Lymphoma with an Elevated Parathyroid Hormone-Related Peptide Associated with Early Richter Transformation
por: Bains, Ashish, et al.
Publicado: (2021)

IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA
por: Tashjian, Armen H., et al.
Publicado: (1964)

Elevated Levels of 1,25-Dihydroxyvitamin D in Plasma as a Missing Risk Factor for Celiac Disease
por: Bittker, Seth Scott
Publicado: (2020)

SUN-LB086 Hypercalcemia in Metastatic Cholangiocarcinoma Due to Coexisting Elevated Parathyroid Hormone Related Protein (PTHrP) and 1,25-Dihydroxy Vitamin D (Calcitriol): A Case Report
por: Sharma, Rajeev
Publicado: (2019)

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis
por: Nguyen, H. Bryant, et al.
Publicado: (2013)

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
por: Faye, Pierre Antoine, et al.
Publicado: (2019)

Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein
por: Christensen, Bryce R, et al.
Publicado: (2022)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3
por: Halicka, H. Dorota, et al.
Publicado: (2012)

The relationship of 1,25-dihydroxyvitamin D and Vitamin D binding protein in periodontitis
por: Rafique, Sara, et al.
Publicado: (2019)

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019)

Childhood Hypercalciuric Hypercalcemia With Elevated Vitamin D and Suppressed Parathyroid Hormone: Long-Term Follow Up
por: Gurevich, Evgenia, et al.
Publicado: (2021)

SAT240 Recurrent Hypercalcemia Due To 1,25 Dihydroxy Vitamin D Elevation Of Unclear Etiology
por: Javvaji, Abhiram, et al.
Publicado: (2023)

Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer
por: Takeda, Katsushi, et al.
Publicado: (2017)

8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D(3)-induced growth inhibition without affecting 1,25-dihydroxyvitamin D(3)-stimulated differentiation of primary mouse epidermal keratinocytes
por: Bollag, Wendy B, et al.
Publicado: (2004)

Richter's Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide
por: Watanabe, Naoki, et al.
Publicado: (2017)

Hypercalcemia due to parathyroid hormone-related peptide secreted by neuroendocrine dedifferentiated prostate cancer
por: Ando, Takashi, et al.
Publicado: (2018)

25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2020)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
por: Jeffery, Louisa E., et al.
Publicado: (2018)

Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy
por: Zeng, Xiaoyun, et al.
Publicado: (2017)

SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

1,25-Dihydroxyvitamin D3 alleviates hyperandrogen-induced ferroptosis in KGN cells
por: Jiang, Yijie, et al.
Publicado: (2023)

1,25-Dihydroxyvitamin D(3) regulates furin-mediated FGF23 cleavage
por: Xie, Han, et al.
Publicado: (2023)

The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model
por: Santucci, Kimberly L., et al.
Publicado: (2011)

Lithium-induced hypercalcemia with normal parathyroid hormone: A case report
por: Dorflinger, Charles, et al.
Publicado: (2019)

Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report
por: Pitts, Stephanie, et al.
Publicado: (2023)

Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
por: Bech, Anneke, et al.
Publicado: (2012)

EXPRESSION OF PARATHYROID HORMONE‐RELATED PROTEIN mRNA IN TUMORS OBTAINED FROM PATIENTS WITH HUMORAL HYPERCALCEMIA OF MALIGNANCY
por: Honda, Satoshi, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_m9g8ta1kjptd5j3gf3fqrjku1h